The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,587
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 801–900 of 1,002
B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers
Chou, W., Chen, W., Hsiung, C., Hu, L., Yu, J., Hsu, H.-M., & Shen, C. (2017) · Scientific Reports · doi:10.1038/srep44089 · Cited by 27
Khiabanian, H., Hirshfield, K. M., Goldfinger, M., Bird, S., Stein, M. N., Aisner, J., Toppmeyer, D., Wong, S. T.-L., Chan, N., Dhar, K., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00148 · Cited by 28
Melloy, P. G. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22820 · Cited by 26
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
Bockstal, M. V., Agahozo, M. C., van Marion, R., Atmodimedjo, P. N., Sleddens, H. F. B. M., Dinjens, W. N. M., Visser, L. L., Lips, E. H., Wesseling, J., & van Deurzen, C. H. M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12650 · Cited by 27
Xiao, L., Lin, S., Xu, W., & Sun, E. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01388-z · Cited by 26
(Single-stranded DNA) gaps in understanding BRCAness
Schreuder, A., Wendel, T. J., Dorresteijn, C. G. V., & Noordermeer, S. M. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.013 · Cited by 25
Identification of Single Nucleotide Non-coding Driver Mutations in Cancer
Gan, K. A., Pro, S. C., Sewell, J. A., & Bass, J. I. F. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00016 · Cited by 30
Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer
Nguyen, B., Veys, I., Leduc, S., Barèche, Y., Majjaj, S., Brown, D. N., Boeckx, B., Lambrechts, D., Sotiriou, C. P., Larsimont, D., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz023 · Cited by 26
Self-citationReviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
Macedo, G. S., Alemar, B., & Ashton‐Prolla, P. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0104 · Cited by 28
Kim, Y.-A., Wójtowicz, D., Basso, R. S., Sason, I., Robinson, W., Hochbaum, D. S., Leiserson, M. D. M., Sharan, R., Vadin, F., & Przytycka, T. M. (2020) · Genome Medicine · doi:10.1186/s13073-020-00745-2 · Cited by 25
Suñé-Pou, M., Limeres, M. J., Moreno‐Castro, C., Hernández-Munaín, C., Suñé-Negre, J. M., Cuestas, M. L., & Suñé, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00731 · Cited by 27
The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
Miklikova, S., Trnkova, L., Plavá, J., Boháč, M., Kuniaková, M., & Cihova, M. (2021) · Cancers · doi:10.3390/cancers13030575 · Cited by 27
A synergetic effect of BARD1 mutations on tumorigenesis
Li, W., Gu, X., Liu, C., Shi, Y., Wang, P., Zhang, N., Wu, R., Leng, L., Xie, B., Song, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21519-3 · Cited by 28
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer
Börcsök, J., Dióssy, M., Sztupinszki, Z. M., Prósz, A. G., Tisza, V., Spisák, S., Rusz, O., Stormoen, D. R., Pappot, H., Csabai, I., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-5037 · Cited by 27
Li, X., Kumar, S., Harmanci, A. O., Li, S., Kitchen, R. R., Zhang, Y., Wali, V. B., Reddy, S. M., Woodward, W. A., Reuben, J. M., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00879-x · Cited by 26
Self-citationSingle-stranded DNA binding proteins influence APOBEC3A substrate preference
Brown, A. L., Collins, C. D., Thompson, S., Coxon, M., Mertz, T. M., & Roberts, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00435-y · Cited by 26
How asymmetric DNA replication achieves symmetrical fidelity
Zhou, Z.-X., Lujan, S. A., Burkholder, A., Charles, J. S., Dahl, J. M., Farrell, C. E., Williams, J. S., & Kunkel, T. A. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00691-6 · Cited by 26
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Sivapalan, L., Thorn, G. J., Gadaleta, E., Kocher, H. M., Ross‐Adams, H., & Chelala, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-09387-6 · Cited by 26
Genomic instability in early systemic sclerosis
Gniadecki, R., Iyer, A., Hennessey, D., Khan, L., O’Keefe, S. L., Redmond, D., Storek, J., Durand, C., Tervaert, J. W. C., & Osman, M. S. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102847 · Cited by 26
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
van der Wiel, A. M.-M. A., Schuitmaker, L., Cong, Y., Theys, J., van Hoeck, A., Vens, C., Lambin, P., Yaromina, A., & Dubois, L. J. (2022) · Cancers · doi:10.3390/cancers14174157 · Cited by 28
Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator
Khandekar, A., Vangara, R., Barnes, M. D., Díaz‐Gay, M., Abbasi, A., Bergstrom, E. N., Steele, C. D., Pillay, N., & Alexandrov, L. B. (2023) · BMC Genomics · doi:10.1186/s12864-023-09584-y · Cited by 26
Self-citationFitzpatrick, A., Iravani, M., Mills, A., Vicente, D., Alaguthurai, T., Roxanis, I., Turner, N. C., Haider, S. A., Tutt, A. N. J., & Isacke, C. M. (2023) · Nature Communications · doi:10.1038/s41467-023-43242-x · Cited by 26
Self-citationSomatic structural variation and cancer
Tubío, J. M. C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv016 · Cited by 27
Whole‐exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast
de Beça, F. F., Lee, S., Pareja, F. G., Paula, A. D. C., Selenica, P., Ferrando, L., Gularte‐Mérida, R., Wen, H. Y., Zhang, H., Guerini‐Rocco, E., et al. (2019) · Histopathology · doi:10.1111/his.13962 · Cited by 26
The genomic landscape of metastasis in treatment-naïve breast cancer models
Ross, C. R., Szczepanek, K., Lee, M. Y., Yang, H. H., Qiu, T., Sanford, J. D., & Hunter, K. W. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008743 · Cited by 25
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy
Liu, J., Tran, D., Xue, L., Wiley, B. J., Vlasschaert, C., Watson, C. J., MacGregor, H. A. J., Zong, X., Chan, I. C. C., Das, I., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02250-x · Cited by 28
Zacksenhaus, E., Liu, J.-K., Jiang, Z., Yao, Y., Xia, L., Shrestha, M., & Ben‐David, Y. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.003 · Cited by 28
The enigmatic role of RUNX 1 in female‐related cancers – current knowledge & future perspectives
Riggio, A. I., & Blyth, K. (2017) · FEBS Journal · doi:10.1111/febs.14059 · Cited by 25
Watanabe, K., Yamamoto, S., Sakaguti, S., Isayama, K., Oka, M., Nagano, H., & Mizukami, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-34290-1 · Cited by 24
The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment
Rabellino, A., & Khanna, K. K. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1738332 · Cited by 25
Freitag, C. E., Mei, P., Wei, L., Parwani, A. V., & Li, Z. (2020) · Human Pathology · doi:10.1016/j.humpath.2020.05.005 · Cited by 25
Biswas, A., Rajesh, Y., Mitra, P., & Mandal, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188389 · Cited by 25
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
Cipriano, É., & Mesquita, A. (2021) · Breast Cancer Basic and Clinical Research · doi:10.1177/11782234211002491 · Cited by 26
Unraveling the genomic landscape of colorectal cancer through mutational signatures
Díaz‐Gay, M., & Alexandrov, L. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.03.003 · Cited by 28
Self-citationGuégan, J., Pollet, J., Ginestier, C., Charafe‐Jauffret, E., Peter, M. E., & Legembre, P. (2021) · iScience · doi:10.1016/j.isci.2021.103538 · Cited by 25
Caught in motion: human NTHL1 undergoes interdomain rearrangement necessary for catalysis
Carroll, B. L., Zahn, K. E., Hanley, J. P., Wallace, S. S., Dragon, J. A., & Doublié, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1162 · Cited by 26
Genetic alterations shaping tumor response to anti-EGFR therapies
Vaquero, J., Pavy, A., Gonzalez‐Sanchez, E., Meredith, M., Arbelaiz, A., & Fouassier, L. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100863 · Cited by 26
Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer
Ross, J. S., & Gay, L. M. (2016) · Pathology · doi:10.1016/j.pathol.2016.11.005 · Cited by 25
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
Saunus, J. M., Reed, A. E. M., Lim, M., & Lakhani, S. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010152 · Cited by 25
Self-citationAltered TERT promoter and other genomic regulatory elements: occurrence and impact
Heidenreich, B., & Kumar, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30735 · Cited by 26
Applications of RNA Indexes for Precision Oncology in Breast Cancer
Ma, L., Liang, Z., Zhou, H., & Qu, L. (2018) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.03.002 · Cited by 27
Yang, J., Wei, X., Tufan, T., Kuscu, C., Unlu, H., Farooq, S., Demirtas, E., Paschal, B. M., & Adli, M. (2018) · Genome biology · doi:10.1186/s13059-018-1572-4 · Cited by 24
High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer
Garinet, S., Pignot, G., Vacher, S., Goux, C. L., Schnitzler, A., Chemlali, W., Sirab, N., Delongchamps, N. B., Zerbib, M., Sibony, M., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0363 · Cited by 25
Review ctDNA and Breast Cancer
Clatot, F. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_12 · Cited by 25
Origins of chromosome instability unveiled by coupled imaging and genomics
Cosenza, M. R., Gaiatto, A., Erarslan-Uysal, B., Andrades, Á., Sautter, N. L., Simunovic, M., Jendrusch, M., Zumalave, S., Rausch, T., Halavatyi, A. A., et al. (2025) · Nature · doi:10.1038/s41586-025-09632-5 · Cited by 28
Kyrochristos, I. D., Ziogas, D. E., & Roukos, D. H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21549 · Cited by 25
Teneurins: An Integrative Molecular, Functional, and Biomedical Overview of Their Role in Cancer
Rebolledo‐Jaramillo, B., & Ziegler, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00937 · Cited by 23
Friedlaender, A., Vuilleumier, A., Viassolo, V., Ayme, A., Talhouet, S. D., Combes, J., Péron, J., Bodmer, A., Giraud, S., Buisson, A., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05127-2 · Cited by 24
Kim, H.-Y., Choi, H., Lee, J., & Kong, G. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz003 · Cited by 24
Self-citationEpigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting)
Ghasemi, S., Xu, S., Nabavi, S. M., Amirkhani, M. A., Sureda, A., Tejada, S., & Lorigooini, Z. (2021) · Phytotherapy Research · doi:10.1002/ptr.7059 · Cited by 28
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
Zhou, Y.-F., Xiao, Y., Jin, X., Di, G., Jiang, Y., & Shao, Z. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003371 · Cited by 24
Mas-Ponte, D., McCullough, M., & Supek, F. (2022) · Clinical Science · doi:10.1042/cs20210682 · Cited by 24
Chen, X., Sifakis, E. G., Robertson, S., Neo, S., Jun, S.-H., Tong, L., Tay, A. H. M., Lövrot, J., Hellgren, R., Margolin, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209856120 · Cited by 22
Kim, J., Jeong, K., Jun, H., Kim, K., Bae, J. M., Song, M. G., Yi, H., Park, S., Woo, G.-U., Lee, D., et al. (2023) · Human Genomics · doi:10.1186/s40246-022-00447-3 · Cited by 26
Simigdala, N., Chalari, A., Sklirou, A. D., Chavdoula, E., Papafotiou, G., Melissa, P., Kafalidou, A., Paschalidis, N., Pateras, I. S., Athanasiadis, E. I., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04734-7 · Cited by 24
Noncoding RNA mutations in cancer
Zhou, H., Hao, X., Zhang, P., & He, S. (2023) · WIREs RNA · doi:10.1002/wrna.1812 · Cited by 24
Resolving complex structural variants via nanopore sequencing
Romagnoli, S., Bartalucci, N., & Vannucchi, A. M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1213917 · Cited by 28
Arsenic is a potent co-mutagen of ultraviolet light
Speer, R. M., Nandi, S. P., Cooper, K. L., Zhou, X., Yu, H., Guo, Y., Hudson, L. G., Alexandrov, L. B., & Liu, K. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05659-4 · Cited by 27
Self-citationGenome-wide miRNA response to anacardic acid in breast cancer cells
Schultz, D. J., Muluhngwi, P., Alizadeh‐Rad, N., Green, M. A., Rouchka, E. C., Waigel, S. J., & Klinge, C. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184471 · Cited by 24
Mitochondrial mutations in human cancer: Curation of translation
Caudron‐Herger, M., & Diederichs, S. (2017) · RNA Biology · doi:10.1080/15476286.2017.1373239 · Cited by 24
Volinia, S., Druck, T., Paisie, C. A., Schrock, M. S., & Huebner, K. (2017) · Oncotarget · doi:10.18632/oncotarget.22321 · Cited by 26
Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C
Cornish, A. J., Hoang, P. H., Dobbins, S. E., Law, P., Chubb, D., Orlando, G., & Houlston, R. S. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026419 · Cited by 24
Pascual, T., González‐Farré, B., Teixidó, C., Oleaga, L., Oses, G., Ganau, S., Chic, N., Riu-Viladoms, G., Adamo, B., Galván, P., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00012 · Cited by 24
HRness in Breast and Ovarian Cancers
Santos, E. S. D., Lallemand, F., Petitalot, A., Caputo, S. M., & Rouleau, É. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113850 · Cited by 24
Everall, A., Tapinos, A., Hawari, A., Cornish, A. J., Sud, A., Chubb, D., Kinnersley, B., Frangou, A., Barquín, M., Jung, J., et al. (2023) · medRxiv · doi:10.1101/2023.06.07.23290970 · Cited by 24
Self-citationLi, N., Zethoven, M., McInerny, S., Devereux, L. M., Huang, Y., Thio, N., Cheasley, D. A., Gutiérrez‐Enríquez, S., Moles‐Fernández, A., Dı́ez, O., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00255-3 · Cited by 23
Mechanism of DNA replication fork breakage and PARP1 hyperactivation during replication catastrophe
Ortega, P., Bournique, E., Li, J., Sanchez, A., Santiago, G., Harris, B. R., Striepen, J., Maciejowski, J., Green, A. M., & Buisson, R. (2025) · Science Advances · doi:10.1126/sciadv.adu0437 · Cited by 22
Precision oncology: lessons learned and challenges for the future
Yang, H., Shah, R. H., Tegay, D. H., & Onel, K. (2019) · Cancer Management and Research · doi:10.2147/cmar.s201326 · Cited by 25
Denkert, C., Untch, M., Benz, S. C., Schneeweiß, A., Weber, K. E., Schmatloch, S., Jackisch, C., Sinn, H., Golovato, J., Karn, T., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.016 · Cited by 23
Funingana, I.-G., Reinius, M. A. V., Petrillo, A., Ang, J. E., & Brenton, J. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.008 · Cited by 23
Muluhngwi, P., & Klinge, C. M. (2021) · Cancers · doi:10.3390/cancers13143530 · Cited by 23
Galland, L., Roussot, N., Desmoulins, I., Mayeur, D., Kaderbhaï, C., Ilie, S. M., Hennequin, A., Réda, M., Albuisson, J., Arnould, L., et al. (2023) · Cancers · doi:10.3390/cancers15041299 · Cited by 23
THOMAS, M. L., Dubacq, C., Rabut, E., López, B. S., & Guirouilh‐Barbat, J. (2023) · Cells · doi:10.3390/cells12081169 · Cited by 25
Proper RPA acetylation promotes accurate DNA replication and repair
Gan, X., Zhang, Y., Jiang, D., Shi, J., Zhao, H., Xie, C., Wang, Y., Xu, J., Zhang, X., Cai, G., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad291 · Cited by 24
Convergent somatic evolution commences in utero in a germline ribosomopathy
Machado, H. E., Øbro, N. F., Williams, N., Tan, S., Boukerrou, A. Z., Davies, M., Belmonte, M., Mitchell, E., Baxter, E. J., Mende, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40896-5 · Cited by 25
Self-citationSomatic evolution of marine transmissible leukemias in the common cockle, Cerastoderma edule
Bruzos, A. L., Santamarina, M., García‐Souto, D., Díaz, S., Rocha, S., Zamora, J., Lee, Y., Viña-Feás, A., Quail, M. A., Otero, I., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00641-9 · Cited by 20
Self-citationTSPLASSO: A Two-Stage Prior LASSO Algorithm for Gene Selection Using Omics Data
Yang, S.-J., Chen, S., Wang, P., Chen, A.-M., & Tian, T. (2023) · IEEE journal of biomedical and health informatics · doi:10.1109/jbhi.2023.3326485 · Cited by 22
Zhu, B., Mukherjee, A., Machiela, M. J., Song, L., Hua, X., Shi, J., García‐Closas, M., Chanock, S. J., & Chatterjee, N. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.223 · Cited by 23
Yu, H., Jiang, Y., Liu, L., Shan, W., Chu, X., Yang, Z., & Yang, Z.-Q. (2016) · Oncotarget · doi:10.18632/oncotarget.14402 · Cited by 23
Maresca, L., Lodovichi, S., Lorenzoni, A., Cervelli, T., Monaco, R., Spugnesi, L., Tancredi, M., Falaschi, E., Zavaglia, K. M., Landucci, E., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00397 · Cited by 25
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma
Cao, L., Basudan, A., Sikora, M. J., Bahreini, A., Tasdemir, N., Levine, K. M., Jankowitz, R. C., McAuliffe, P. F., Dabbs, D. J., Haupt, S., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.011 · Cited by 23
RUNX1 Dosage in Development and Cancer.
Lie‐A‐Ling, M., Mével, R., Patel, R., Blyth, K., Baena, E., Kouskoff, V., & Lacaud, G. (2020) · PubMed Central · doi:10.14348/molcells.2019.0301 · Cited by 22
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
Kutasovic, J. R., Reed, A. E. M., Sokolova, A., Lakhani, S. R., & Simpson, P. T. (2020) · Cancers · doi:10.3390/cancers12040848 · Cited by 24
Self-citationDai, W., Chung, D. L., Chow, L. K.-Y., Yu, V. Z., Lei, L. C., Leong, M. M., Chan, C. K.-C., Ko, J. M. Y., & Lung, M. L. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2854 · Cited by 24
Yoshino, Y., Fang, Z., Qi, H., Kobayashi, A., & Chiba, N. (2021) · Cancer Science · doi:10.1111/cas.14859 · Cited by 23
Brammeld, J. S., Petljak, M., Martincorena, I., Williams, S. P., García‐Alonso, L., Dalmases, A., Bellosillo, B., Robles‐Espinoza, C. D., Price, S., Barthorpe, S., et al. (2017) · Genome Research · doi:10.1101/gr.213546.116 · Cited by 23
Self-citationSpatial genomics maps the structure, character and evolution of cancer clonesPreprint
Lomakin, A., Svedlund, J., Strell, C., Gatarić, M., Shmatko, A., Park, J. S., Ju, Y. S., Dentro, S. C., Kleshchevnikov, V., Vaskivskyi, V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.439912 · Cited by 23
Self-citationJain, E., Zañudo, J. G. T., McGillicuddy, M., Abravanel, D. L., Thomas, B. S., Kim, D., Balch, S., Navarro, J., Weiss, J. H., Hernandez, T. G., et al. (2023) · medRxiv · doi:10.1101/2023.06.07.23291117 · Cited by 21
Lips, E. H., Debipersad, R. D., Scheerman, C. E., Mulder, L., Sonke, G. S., van der Kolk, L. E., Wesseling, J., Hogervorst, F. B. L., & Nederlof, P. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0198 · Cited by 22
Heetvelde, M. V., Bockstal, M. V., Poppe, B. G., Lambein, K., Rosseel, T., Atanesyan, L., Deforce, D. L. D., Berghe, I. V. D., Leeneer, K. D., Dorpe, J. V., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.026 · Cited by 22
Krais, J. J., & Johnson, N. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa154 · Cited by 22
Li, K., Liao, N., Chen, B., Zhang, G., Wang, Y., Guo, L., Wei, G., Jia, M., Wen, L., Ren, C., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05778-0 · Cited by 22
Duan, J., Bao, C., Xie, Y., Guo, H., Liu, Y., Li, J., Liu, R., Li, P., Bai, J., Yan, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.10.007 · Cited by 21
‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’
Mehmood, S., Faheem, M. Q., Ismail, H., Farhat, S. M., Ali, M., Younis, S., & Asghar, M. N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.783494 · Cited by 22
A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer
Kim, M., Singh, M., Lee, B., Hibbs, M. E., Richardson, K. L., Ellies, L. G., Wintle, L. C., Stuart, L. M., Wang, J. Y., Voon, D. C., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00435-1 · Cited by 22
Mazouzi, A., Moser, S. C., Abascal, F., van den Broek, B., Velasco‐Herrera, M. D. C., van der Heijden, I., Hekkelman, M. L., Drenth, A. P., van der Burg, E., Kroese, L. J., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf4409 · Cited by 21
Self-citationTumour mutations in long noncoding RNAs enhance cell fitness
Esposito, R., Lanzós, A., Uroda, T., Ramnarayanan, S., Büchi, I., Polidori, T., Guillen-Ramirez, H., Mihaljevic, A., Merlin, B. M., Mela, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39160-7 · Cited by 27
Long-range gene regulation in hormone-dependent cancer
Tettey, T. T., Rinaldi, L., & Hager, G. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00603-4 · Cited by 23
Sahu, S., Sullivan, T. L., Mitrophanov, A. Y., Galloux, M., Nousome, D., Southon, E. A., Caylor, D., Mishra, A. P., Evans, C. N., Clapp, M. E., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010940 · Cited by 24
Pozzorini, C., Andre, G., Coletta, T., Buisson, A., Bieler, J., Ferrer, L., Kempfer, R., Saintigny, P., Harlé, A., Vacirca, D., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101344 · Cited by 22
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
